Compare Aventis Pharma with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ALKEM LABORATORIES - Comparison Results

SANOFI INDIA     Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA ALKEM LABORATORIES SANOFI INDIA/
ALKEM LABORATORIES
 
P/E (TTM) x 39.1 - - View Chart
P/BV x 6.9 6.7 102.2% View Chart
Dividend Yield % 1.3 0.6 196.7%  

Financials

 SANOFI INDIA   ALKEM LABORATORIES
EQUITY SHARE DATA
    SANOFI INDIA
Dec-18
ALKEM LABORATORIES
Mar-16
SANOFI INDIA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs6,8401,589 430.5%   
Low Rs4,6301,232 375.8%   
Sales per share (Unadj.) Rs1,203.1417.5 288.2%  
Earnings per share (Unadj.) Rs165.356.3 293.6%  
Cash flow per share (Unadj.) Rs209.964.7 324.3%  
Dividends per share (Unadj.) Rs84.0012.70 661.4%  
Dividend yield (eoy) %1.50.9 162.7%  
Book value per share (Unadj.) Rs963.6292.9 328.9%  
Shares outstanding (eoy) m23.03119.57 19.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.83.4 141.1%   
Avg P/E ratio x34.725.1 138.5%  
P/CF ratio (eoy) x27.321.8 125.4%  
Price / Book Value ratio x6.04.8 123.6%  
Dividend payout %50.822.6 225.3%   
Avg Mkt Cap Rs m132,078168,653 78.3%   
No. of employees `0003.3NA-   
Total wages/salary Rs m4,0689,171 44.4%   
Avg. sales/employee Rs Th8,393.8NM-  
Avg. wages/employee Rs Th1,232.4NM-  
Avg. net profit/employee Rs Th1,153.0NM-  
INCOME DATA
Net Sales Rs m27,70849,915 55.5%  
Other income Rs m8971,645 54.5%   
Total revenues Rs m28,60551,561 55.5%   
Gross profit Rs m6,2358,482 73.5%  
Depreciation Rs m1,0271,006 102.1%   
Interest Rs m7671 1.0%   
Profit before tax Rs m6,0988,451 72.2%   
Minority Interest Rs m0-114 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2921,606 142.7%   
Profit after tax Rs m3,8066,731 56.5%  
Gross profit margin %22.517.0 132.4%  
Effective tax rate %37.619.0 197.8%   
Net profit margin %13.713.5 101.9%  
BALANCE SHEET DATA
Current assets Rs m15,92227,062 58.8%   
Current liabilities Rs m6,23515,324 40.7%   
Net working cap to sales %35.023.5 148.7%  
Current ratio x2.61.8 144.6%  
Inventory Days Days6467 95.7%  
Debtors Days Days2141 50.5%  
Net fixed assets Rs m7,53912,610 59.8%   
Share capital Rs m230239 96.2%   
"Free" reserves Rs m21,96234,490 63.7%   
Net worth Rs m22,19235,027 63.4%   
Long term debt Rs m01,212 0.0%   
Total assets Rs m29,83954,387 54.9%  
Interest coverage x872.113.6 6,411.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.90.9 101.2%   
Return on assets %12.813.6 93.9%  
Return on equity %17.219.2 89.2%  
Return on capital %27.524.9 110.7%  
Exports to sales %012.9 0.0%   
Imports to sales %03.1 0.0%   
Exports (fob) Rs mNA6,461 0.0%   
Imports (cif) Rs mNA1,540 0.0%   
Fx inflow Rs m7,5876,563 115.6%   
Fx outflow Rs m7,1453,012 237.2%   
Net fx Rs m4423,552 12.4%   
CASH FLOW
From Operations Rs m3,7397,259 51.5%  
From Investments Rs m-7311,864 -39.2%  
From Financial Activity Rs m-1,972-9,273 21.3%  
Net Cashflow Rs m1,036-150 -690.7%  

Share Holding

Indian Promoters % 0.0 66.9 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 33.1 43.5%  
FIIs % 14.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 0.0 -  
Shareholders   15,184 68,381 22.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ALEMBIC PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  TORRENT PHARMA  DISHMAN PHARMA  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 21 Points Higher; Banking and Oil & Gas Stocks Witness Buying(Closing)

Indian share markets witnessed buying interest during closing hours today and ended their day marginally higher.

Related Views on News

SANOFI INDIA Announces Quarterly Results (1QFY20); Net Profit Down 2.2% (Quarterly Result Update)

Jul 31, 2019 | Updated on Jul 31, 2019

For the quarter ended June 2019, SANOFI INDIA has posted a net profit of Rs 974 m (down 2.2% YoY). Sales on the other hand came in at Rs 7 bn (up 9.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (4QFY19); Net Profit Up 12.6% (Quarterly Result Update)

May 8, 2019 | Updated on May 8, 2019

For the quarter ended March 2019, SANOFI INDIA has posted a net profit of Rs 929 m (up 12.6% YoY). Sales on the other hand came in at Rs 7 bn (up 16.1% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA 2017-18 Annual Report Analysis (Annual Result Update)

Apr 16, 2019 | Updated on Apr 16, 2019

Here's an analysis of the annual report of SANOFI INDIA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SANOFI INDIA. Also includes updates on the valuation of SANOFI INDIA.

SANOFI INDIA Announces Quarterly Results (3QFY19); Net Profit Up 4.3% (Quarterly Result Update)

Mar 5, 2019 | Updated on Mar 5, 2019

For the quarter ended December 2018, SANOFI INDIA has posted a net profit of Rs 793 m (up 4.3% YoY). Sales on the other hand came in at Rs 7 bn (up 8.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

More Views on News

Most Popular

Is Hawkins Set to Become Our Next Superhero Stock?(The 5 Minute Wrapup)

Nov 1, 2019

After PI Industries, Hawkins has put up a stellar show so far.

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Ditch the Risky Fixed Deposits for Safer 'Bluechip Deposits'(Profit Hunter)

Oct 30, 2019

Most people think stocks are riskier than fixed deposits and bonds. The last quarter century proves otherwise.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Nov 11, 2019 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - GSK PHARMA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS